{"id":2,"date":"2022-11-11T15:20:09","date_gmt":"2022-11-11T19:20:09","guid":{"rendered":"https:\/\/knighttx.com\/?page_id=2"},"modified":"2025-11-24T07:47:15","modified_gmt":"2025-11-24T12:47:15","slug":"home","status":"publish","type":"page","link":"https:\/\/knighttx.com\/fr\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2\" class=\"elementor elementor-2\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ca4b2e0 elementor-section-height-min-height elementor-section-items-top elementor-section-content-top elementor-section-boxed elementor-section-height-default\" data-id=\"ca4b2e0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-a6163bf\" data-id=\"a6163bf\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a78d3ad elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"a78d3ad\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;,&quot;_animation_delay&quot;:0}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l'Am\u00e9rique latine<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-a8aebd4\" data-id=\"a8aebd4\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3eea0e8 elementor-invisible elementor-widget elementor-widget-image\" data-id=\"3eea0e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInRight&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/knighttx.com\/images-global\/banner-topo2024.png\" title=\"\" alt=\"\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e030ab5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e030ab5\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cdc69ce\" data-id=\"cdc69ce\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3faf153 elementor-widget elementor-widget-heading\" data-id=\"3faf153\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Nouvelles<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0c32cf1 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0c32cf1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-933cfa5\" data-id=\"933cfa5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8cad5bc elementor-widget elementor-widget-text-editor\" data-id=\"8cad5bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a id=\"list-item-content-title-2878656\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/05\/09\/2878656\/0\/fr\/Th%C3%A9rapeutique-Knight-conclut-une-entente-exclusive-d-approvisionnement-et-de-distribution-avec-Ironshore-Pharmaceuticals-Development-Inc-pour-JORNAY-PM-pour-le-Canada-et-l-Am%C3%A9rique.html\" target=\"_self\">Th\u00e9rapeutique Knight conclut une entente exclusive d\u2019approvisionnement et de distribution avec Ironshore Pharmaceuticals &amp; Development, Inc. pour JORNAY PM\u00ae pour le Canada et l\u2019Am\u00e9rique latine<\/a><\/p><div id=\"list-item-content-body-2878656\" class=\"list-item-content-body\">MONTR\u00c9AL, 09 mai 2024 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight Inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique sp\u00e9cialis\u00e9e panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui la&#8230;<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a2d125b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"a2d125b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9798935 elementor-widget elementor-widget-text-editor\" data-id=\"9798935\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a id=\"list-item-content-title-2878648\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/05\/09\/2878648\/0\/fr\/Th%C3%A9rapeutique-Knight-d%C3%A9clare-ses-r%C3%A9sultats-du-premier-trimestre-de-2024.html\" target=\"_self\">Th\u00e9rapeutique Knight d\u00e9clare ses r\u00e9sultats du premier trimestre de 2024<\/a><\/p><div id=\"list-item-content-body-2878648\" class=\"list-item-content-body\">MONTR\u00c9AL, 09 mai 2024 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb ou la \u00ab\u00a0Soci\u00e9t\u00e9 \u00bb), une soci\u00e9t\u00e9 pharmaceutique sp\u00e9cialis\u00e9e panam\u00e9ricaine (\u00e0 l\u2019exclusion des \u00c9.-U.) de&#8230;<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-509051c elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"509051c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-02b1150 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"02b1150\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-62a36fa\" data-id=\"62a36fa\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0f1e01a elementor-widget elementor-widget-feedzy-rss-feeds\" data-id=\"0f1e01a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"feedzy-rss-feeds.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"feedzy-a2bf70c287d6f26fd060a01661362d39 feedzy-rss\">\n\t\t<ul class=\"feedzy-default\">\n\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/05\/08\/3290958\/0\/fr\/Th%C3%A9rapeutique-Knight-annonce-l-approbation-r%C3%A9glementaire-de-TAVALISSE-au-Br%C3%A9sil.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tTh\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de TAVALISSE\u00ae au Br\u00e9sil\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>MONTR\u00c9AL,  08 mai 2026  (GLOBE NEWSWIRE) -- Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab\u2009Knight\u2009\u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui que sa filiale br\u00e9silienne, United Medical Ltda., a re\u00e7u l\u2019autorisation de ANVISA pour TAVALISSE\u00ae (fostamatinib disodique hexahydrat\u00e9) pour le traitement [&hellip;]<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/05\/07\/3289748\/0\/fr\/Th%C3%A9rapeutique-Knight-d%C3%A9clare-ses-r%C3%A9sultats-du-premier-trimestre-de-l-exercice-2026.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tTh\u00e9rapeutique Knight d\u00e9clare ses r\u00e9sultats du premier trimestre de l\u2019exercice 2026\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Augmentation des pr\u00e9visions des produits des activit\u00e9s ordinaires \u00e0 une fourchette de 510\u00a0millions de dollars \u00e0 525\u00a0millions de dollarsNiveau record trimestriel des produits des activit\u00e9s ordinaires, du BAIIA ajust\u00e91 et du BAIIA ajust\u00e9 par action1 depuis la cr\u00e9ation<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t<\/ul>\n<\/div>\n<style type=\"text\/css\" media=\"all\">.feedzy-rss .rss_item .rss_image{float:left;position:relative;border:none;text-decoration:none;max-width:100%}.feedzy-rss .rss_item .rss_image span{display:inline-block;position:absolute;width:100%;height:100%;background-position:50%;background-size:cover}.feedzy-rss .rss_item .rss_image{margin:.3em 1em 0 0;content-visibility:auto}.feedzy-rss ul{list-style:none}.feedzy-rss ul li{display:inline-block}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c502bf4 elementor-widget elementor-widget-spacer\" data-id=\"c502bf4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a69fb2d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a69fb2d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2a3201f\" data-id=\"2a3201f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-95c9352 elementor-align-center elementor-hidden-tablet elementor-widget elementor-widget-button\" data-id=\"95c9352\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm elementor-animation-grow\" href=\"https:\/\/investors.knighttx.com\/French\/nouvelles\/default.aspx\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Voir plus <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b64ba3c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b64ba3c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-44d788c\" data-id=\"44d788c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c3d9146 elementor-widget elementor-widget-spacer\" data-id=\"c3d9146\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l&#8217;Am\u00e9rique latine Nouvelles Th\u00e9rapeutique Knight conclut une entente exclusive d\u2019approvisionnement et de distribution avec Ironshore Pharmaceuticals &amp; Development, Inc. pour JORNAY PM\u00ae pour le Canada et l\u2019Am\u00e9rique latine MONTR\u00c9AL, 09 mai 2024 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight Inc. (TSX : GUD) (\u00ab Knight \u00bb), [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":497,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":79679,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions\/79679"}],"wp:attachment":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}